ID   HeLa-ACE2
AC   CVCL_B3LW
DR   JCRB; JCRB1845
DR   Wikidata; Q110432867
RX   PubMed=22496216;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1845
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3,14.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12,13
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1276 ! HeLa 229
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
RX   PubMed=22496216; DOI=10.1128/JVI.00094-12; PMCID=PMC3393535;
RA   Kawase M., Shirato K., van der Hoek L., Taguchi F., Matsuyama S.;
RT   "Simultaneous treatment of human bronchial epithelial cells with
RT   serine and cysteine protease inhibitors prevents severe acute
RT   respiratory syndrome coronavirus entry.";
RL   J. Virol. 86:6537-6545(2012).
//